Camptosar and Temaz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Camptosar (irinotecan hydrochloride) and Temaz (temazepam). Common drug interactions include coma among females and transient ischaemic attack among males.

The phase IV clinical study analyzes what interactions people have when they take Camptosar and Temaz. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Camptosar?

Camptosar has active ingredients of irinotecan hydrochloride. eHealthMe is studying from 7,145 Camptosar users. Check the latest studies of Camptosar.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.



On Jul, 12, 2026

26 people who take Camptosar and Temaz together, and have interactions are studied.

Camptosar and Temaz drug interactions.

What are the common drug interactions of Camptosar and Temaz, by gender? *:

female:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Hypoglycaemia (deficiency of glucose in the bloodstream)
  3. Hypotension (abnormally low blood pressure)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Abscess limb (limb infection)
  6. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  7. Blood glucose increased
  8. Blood potassium decreased
  9. Blood pressure decreased
  10. Cellulitis (infection under the skin)

male:

  1. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  2. Headache (pain in head)
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Coordination abnormal (abnormal movement)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Muscle cramps (painful sensations caused by muscle contraction)
  7. Pulmonary oedema (fluid accumulation in the lungs)
  8. Pulsus bigeminus (groups of two heartbeats close together followed by a longer pause)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Supraventricular extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle)

What are the common drug interactions of Camptosar and Temaz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Blood glucose increased
  2. Death
  3. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)

30-39:

  1. Abscess limb (limb infection)
  2. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  3. Cellulitis (infection under the skin)
  4. Wound infection staphylococcal

40-49:

  1. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  2. Headache (pain in head)
  3. Monoparesis (one limb is very weak, but not completely paralyzed)
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Facial palsy (paralysis of face nerve)
  6. Sensory loss (senses loss)
  7. Alveolitis (inflammation in the socket of a tooth)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Coordination abnormal (abnormal movement)
  10. Pulmonary oedema (fluid accumulation in the lungs)

50-59:

  1. Bereavement reaction
  2. Depression
  3. Intestinal perforation (complete penetration of the wall of the intestine)
  4. Intracardiac thrombus (presence of a circumscribed mass with heart wall)
  5. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Diarrhoea
  3. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  4. Asthenia (weakness)
  5. Ataxia (loss of full control of bodily movements)
  6. Blood potassium decreased
  7. Collapse (sudden functional breakdown)
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Fall
  10. Heart rate irregular

What are the existing conditions these people have? *

  1. Colon Cancer: 3 people, 11.54%
  2. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 2 people, 7.69%
  3. Colon Cancer Stage Iii: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Camptosar and Temaz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Camptosar and Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Camptosar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Camptosar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on irinotecan hydrochloride and temazepam (the active ingredients of Camptosar and Temaz, respectively), and Camptosar and Temaz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: